DCAT Value Chain Insights Podcast - Older Episodes

Podcast Archive

Listen to specially selected articles from our website that feature in-depth analysis on the issues impacting the business of pharmaceutical development and manufacturing.

  applepodcastbadge copy   google podcasts badge8x     spotify badge

Pharma Company on the Move: The New AbbVie
May 22, 2020

In this podcast, we feature an article that examines the new AbbVie, including the key products and expanded manufacturing networking, resulting from its recent acquisition of Allergan. 

Re-inventing US Pharma Mfg and Supply Chains
May 15, 2020

In this podcast, we feature an article about the Association for Accessible Medicines’ blueprint to facilitate a repatriation of pharma manufacturing to the US.

Supplying Potential COVID-19 Treatments & Vaccines
May 13, 2020

In this podcast, we outline the manufacturing strategies and alliances that are in play to develop and supply treatments and vaccines against COVID-19.

This podcast is sponsored by: CordenPharma   

Drug Development in the Wake of COVID-19
May 1, 2020

In this podcast, we feature an article that examines the effect of COVID-19 on drug development, clinical trials, regulatory review, and new drug approvals.

This podcast is sponsored by: CordenPharma 

A Top 10 Watch List: Biologics and Biomanufacturing
April 27, 2020

In this podcast we feature DCAT Value Chain Insights’ Top 10 Watch List for Biologics and Biomanufacturing.  

This podcast is sponsored by: CordenPharma   

Facilitating Sourcing in the Wake of COVID-19
April 17, 2020

In this podcast, we feature an article that outlines the guidance issued by EU authorities to provide flexibility in sourcing for crucial medicines for the treatment of COVID-19.

This podcast is sponsored by: CordenPharma   

COVID-19's Impact on Global Pharma Supply Chains
April 06, 2020

In this podcast, we feature an article that reports on the concerns raised by industry groups, including reduced availability of international air transportation and increasing costs for shipping medicines into the US.

This podcast is sponsored by: CordenPharma   

Indian Government Looks to Increase API Manufacturing
March 27, 2020

In this podcast, we feature an article that looks at the Indian government’s $1.3-billion multi-year plan to increase domestic production of key starting materials and active pharmaceutical ingredients and its potential impact on global supply chains.

This podcast is sponsored by: CordenPharma   

Drug Supply Chains and US-Based Manufacturing
March 23, 2020

What does the global nature of the pharmaceutical supply chain mean for US policy? In this podcast, we feature an article that looks at proposals from members of Congress and the federal government to incentivize domestic drug manufacturing in the US. 

This podcast is sponsored by: CordenPharma   

Blockbuster Watch for 2020: New Market Entrants
March 2, 2020

What are the new blockbuster medicines to watch? In this podcast we feature an article that examines the eleven medicines projected to enter the market in 2020 and achieve blockbuster status by 2024, according to a recent analysis by Clarivate Analytics’ Cortellis Forecast Team.

This podcast is sponsored by: CordenPharma   

Orphan Drugs: Bearing Revenue Gains or Not? 
February 25, 2020

Over the past several years, orphan drugs have accounted for more than 40% of new drug approvals by the FDA.  In this podcast, we showcase an article that explores whether they are producing the revenue gains pharma companies are seeking or if they are too niche? 

This podcast is sponsored by: CordenPharma   

Emerging Biopharma Companies: Tracking Their Contribution to Innovation
February 14, 2020

To what extent do emerging pharma companies contribute to the pharmaceutical industry’s pipeline and new product growth? In this podcast, we showcase an article examining a recent report by IQVIA that analyzes emerging bio pharma companies’ contribution to innovation.

This podcast is sponsored by: CordenPharma   

20-20 Insights and Outlook for the CDMO Market
January 15, 2020

The conditions are favorable for another strong year of performance for CDMOs. In this podcast, we showcase an article written by Jim Miller, Consultant and Content Advisor at DCAT, that examines industry fundamentals and an outlook for pharma outsourcing in 2020.

This podcast is sponsored by: CordenPharma